Precigen, Inc. (PGEN): Price and Financial Metrics

Precigen, Inc. (PGEN): $1.45

0.01 (-0.34%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add PGEN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#304 of 363

in industry

PGEN Price/Volume Stats

Current price $1.45 52-week high $1.88
Prev. close $1.45 52-week low $0.84
Day low $1.42 Volume 287,291
Day high $1.47 Avg. volume 1,137,749
50-day MA $1.46 Dividend yield N/A
200-day MA $1.33 Market Cap 359.69M

PGEN Stock Price Chart Interactive Chart >

PGEN POWR Grades

  • PGEN scores best on the Growth dimension, with a Growth rank ahead of 42.93% of US stocks.
  • PGEN's strongest trending metric is Value; it's been moving down over the last 26 weeks.
  • PGEN ranks lowest in Value; there it ranks in the 3rd percentile.

PGEN Stock Summary

  • With a price/sales ratio of 47.87, PRECIGEN INC has a higher such ratio than 96.54% of stocks in our set.
  • With a year-over-year growth in debt of -91.88%, PRECIGEN INC's debt growth rate surpasses merely 1.29% of about US stocks.
  • As for revenue growth, note that PGEN's revenue has grown -91.09% over the past 12 months; that beats the revenue growth of merely 1.56% of US companies in our set.
  • Stocks that are quantitatively similar to PGEN, based on their financial statements, market capitalization, and price volatility, are SAGE, TDUP, GANX, RYTM, and LUMO.
  • PGEN's SEC filings can be seen here. And to visit PRECIGEN INC's official web site, go to www.precigen.com.

PGEN Valuation Summary

  • PGEN's price/earnings ratio is -3.9; this is 113.38% lower than that of the median Healthcare stock.
  • Over the past 126 months, PGEN's price/sales ratio has gone down 2850.9.

Below are key valuation metrics over time for PGEN.

Stock Date P/S P/B P/E EV/EBIT
PGEN 2023-12-29 49.3 2.3 -3.9 -3.9
PGEN 2023-12-28 51.9 2.4 -4.1 -4.1
PGEN 2023-12-27 51.6 2.4 -4.1 -4.1
PGEN 2023-12-26 49.7 2.3 -4.0 -4.0
PGEN 2023-12-22 46.4 2.1 -3.7 -3.7
PGEN 2023-12-21 41.6 1.9 -3.3 -3.3

PGEN Growth Metrics

    Its 3 year revenue growth rate is now at -22.78%.
  • The year over year revenue growth rate now stands at 13.83%.
  • The year over year net cashflow from operations growth rate now stands at 11.41%.
Over the past 33 months, PGEN's revenue has gone down $14,847,000.

The table below shows PGEN's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 75.875 -64.238 25.459
2022-06-30 80.714 -57.447 -91.684
2022-03-31 111.383 -58.17 -94.099
2021-12-31 103.873 -55.771 -92.166
2021-09-30 98.985 -57.651 -108.793
2021-06-30 101.007 -59.633 -108.537

PGEN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • PGEN has a Quality Grade of C, ranking ahead of 33.59% of graded US stocks.
  • PGEN's asset turnover comes in at 0.277 -- ranking 449th of 561 Business Services stocks.
  • V, GOVX, and CELP are the stocks whose asset turnover ratios are most correlated with PGEN.

The table below shows PGEN's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.277 0.456 -0.241
2021-03-31 0.276 0.439 -0.310
2020-12-31 0.291 0.462 -0.418
2020-09-30 0.237 0.398 -0.717
2020-06-30 0.201 0.376 -0.731
2020-03-31 0.183 0.387 -0.659

PGEN Price Target

For more insight on analysts targets of PGEN, see our PGEN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $9.00 Average Broker Recommendation 1.5 (Moderate Buy)

Precigen, Inc. (PGEN) Company Bio


Precigen, Inc. (formerly Intrexon Corporation) provides synthetic biology services. The Company designs and produces modular DNA control systems and applications for human therapeutics, protein production, industrial products, agricultural biotechnology, and animal sciences. The company was founded in 1998 and is based in Germantown, Maryland.


PGEN Latest News Stream


Event/Time News Detail
Loading, please wait...

PGEN Latest Social Stream


Loading social stream, please wait...

View Full PGEN Social Stream

Latest PGEN News From Around the Web

Below are the latest news stories about PRECIGEN INC that investors may wish to consider to help them evaluate PGEN as an investment opportunity.

Even after rising 15% this past week, Precigen (NASDAQ:PGEN) shareholders are still down 86% over the past three years

Precigen, Inc. ( NASDAQ:PGEN ) shareholders should be happy to see the share price up 16% in the last month. But the...

Yahoo | December 27, 2023

Precigen to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced Helen Sabzevari, PhD, President and CEO of Precigen, will present a corporate and clinical overview at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024 at 5:15 PM PT/8:15 PM ET in San Francisco, California.

Yahoo | December 18, 2023

5 ‘Jackpot’ Stocks to Buy for 2024 for 10X Gains

These stocks to buy have the potential to take your portfolio to the next level thanks to the cutting-edge technology they represent.

Thomas Yeung on InvestorPlace | December 4, 2023

Precigen to Participate in the JMP Securities Hematology and Oncology Summit

Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced that Helen Sabzevari, PhD, President and CEO of Precigen, will participate in a fireside chat at the JMP Securities Hematology and Oncology Summit on Wednesday, December 6, 2023 at 3:00 PM ET.

Yahoo | November 29, 2023

3 Penny Stocks to Buy to Turn $1 into $100: November 2023

Are you looking for outsized gains for your portfolio.

Gabriel Osorio-Mazzilli on InvestorPlace | November 22, 2023

Read More 'PGEN' Stories Here

PGEN Price Returns

1-mo -10.49%
3-mo 8.21%
6-mo 2.11%
1-year 42.16%
3-year -78.69%
5-year -72.43%
YTD 8.21%
2023 -11.84%
2022 -59.03%
2021 -63.63%
2020 86.13%
2019 -16.21%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!